Allied Biotech Corporation (TPEX:1780)
Taiwan · Delayed Price · Currency is TWD 26.30
+0.40 (1.54%)
Mar 6, 2026, 9:25 AM CST
Allied Biotech Market Cap
Allied Biotech has a market cap or net worth of 2.49 billion as of March 5, 2026. Its market cap has increased by 47.08% in one year.
Market Cap
2.49B
Enterprise Value
2.45B
Revenue
821.81M
Ranking
n/a
PE Ratio
26.42
Stock Price
26.30
Market Cap Chart
Since April 29, 2010, Allied Biotech's market cap has increased from 1.27B to 2.49B, an increase of 95.59%. That is a compound annual growth rate of 4.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 2.49B | 12.12% |
| Dec 31, 2025 | 2.22B | 33.44% |
| Dec 31, 2024 | 1.67B | 5.41% |
| Dec 29, 2023 | 1.58B | 17.93% |
| Dec 30, 2022 | 1.34B | -7.84% |
| Dec 30, 2021 | 1.45B | -9.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orient EuroPharma | 3.84B |
| Easywell Biomedicals | 3.68B |
| Merdury Biopharmaceutical | 3.56B |
| LIWANLI Innovation | 3.04B |
| Maywufa Company | 2.94B |
| PhytoHealth | 2.73B |
| Johnson Chemical Pharmaceutical Works | 2.55B |
| Golden Biotechnology | 2.30B |